POST FINASTERIDE SYNDROME (PSF)

Five alpha-reductase inhibitors used for prostate baldness and adenoma
can cause irreversible damage, according to the Post-Finasteride Syndrome Foundation. See PowerPoint

Androgen biosynthesis is complex and is not part of this presentation.
However, the reader can get an idea by consulting the link below:

https://en.wikipedia.org/wiki/Androgen#Biosynthesis

More simply, by looking at

BIOCHEMICAL DIAGNOSIS

In the diagram below, we can already understand that testosterone is a precursor of dihydrotestosterone (that is the sex hormone itself). Testosterone is also a precursor of estradiol (that is the proliferative female hormone). By preventing the production of dihydrotestosterone, the 5-alpha-reductase inhibitors promote the production of estradiol and thus the male feminization .

 

 

The pituitary gland also controls these biochemical reactions.

Believing that 5-alpha-reductase inhibitors are the correct treatments for baldness and prostate adenoma is simplistic and even dangerous reasoning.

***

A man with post-finasteride syndrome must analyze his biology  thoroughly to correct his biochemistry.

 

Between 1993 and 2020, iatrogeny has reproduced and aggravated two pathologies :

 

The syndrome of prostate atrophy (1979)

and

The androgenic disease of andropause (1988)

through the use of
5-alpha-reductase for illusory and dangerous prescriptions